PRI is a drug discovery and development company.

We have spun out more than 25 companies and incubated 40+ technologies. Our development model focuses on reaching multiple value inflection points with the ultimate goal of finding a partner for an exit or raising venture capital financing before an IND. Currently, PRI is incubating seven companies.